Johnson & Johnson owes $1bn to Auris Health, Inc. shareholders for breaching the terms of its 2019 acquisition of the robotics developer, the Delaware Court of Chancery ruled on 4 September.
J&J paid $3.4bn upfront to purchase Auris and committed to pay as much as $2.4bn more as milestones were met...
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?